Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Biomarker Exploration of 2nd Line Aflibercept in Combination With FOLFIRI in Advanced Colorectal Cancer

NCT04810585 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04810585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04810585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Biomarker Exploration of 2nd Line Aflibercept in Combination With FOLFIRI in Advanced Colorectal Cancer
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Unknown status
Start date
April 20, 2020
Completion date
October 31, 2025
Enrollment
153 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent or metastatic colorectal cancer